Showing 1261 - 1280 of 2722 results
Australia's home of nuclear medicine welcomes new Board Members
ANSTO welcomes new Board Chair Michael Quigley
Strategic agreement signed with the University of Wollongong continues research collaborations
ANSTO continues a longstanding, mutually-beneficial research relationship with the University of Wollongong following the signing of a strategic agreement this week.
COVIDSafe Plan Victoria
This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.
ANSTO scientists will participate in three new ARC Industrial Transformation Training Centres
ANSTO scientists are participating investigators in three new ARC Industrial Transformation Training Centres, recently announced by the Government.
Neutron scattering helping conserve the world’s great historic monuments
Successfully navigating the challenges of replacing a component in a nuclear reactor
The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.
ANSTO continues to take advice about bushfires
ANSTO providing support to emergency services, closed to non-essential staff.
Health
ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week. Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.
ANSTO shining a light on the Australian Synchrotron's $100M BRIGHT beamlines
A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.
Natural variability in hydrological systems
Research to improve knowledge of natural variability in rainfall and recharge by monitoring hydrological processes in key regions and reconstruct water recharge history.
ANSTO Minerals shares expertise at international workshop
Development of radiotracers
The Biosciences team undertakes the radiolabelling of chemical, biochemical. biological or material vector for the purpose of radiotracing in living systems.
Significant progress on breakthrough cancer therapy
Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.
ANSTO provides groundwork for promising new nuclear medicine
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
ANSTO delivers custom tailored radioisotopes bound for space applications with tech incubator entX
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
Operation Art winner has passion for science
Year 11 STEM student and aspiring physicist was given the opportunity of a lifetime to tour ANSTO’s Lucas Heights campus and meet some of Australia’s top researchers.
Distinguished Lecture with Fiona Wood
ANSTO expert recognised for technological innovation in critical minerals processing
Minerals Principal Consultant, Dr Karin Soldenhoff, was honoured with the 2024 NSW Women in Mining -Technological Innovation award last week for her work as technical lead on the Australia Strategic Metals (ASM) Dubbo Project, and development of a new solvent extraction technology to separate rare earth and other critical elements.